Haemophilus Influenzae Type b Diseases Completed Phase 3 Trials for Pentaerythritol tetranitrate (DB06154)

Also known as: Haemophilus Influenzae Type b Disease

IndicationStatusPhase
DBCOND0035438 (Haemophilus Influenzae Type b Diseases)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00586612Primary & Booster Study to Evaluate the Immunogenicity and Safety of Menitorix Vaccine in Preterm InfantsPrevention
NCT00322335Long-term Persistence Study to Assess a Booster Dose of GSK Biologicals' Hib-MenCPrevention
NCT00327184Primary & Booster Study in Infants to Demonstrate Non-inferiority, Persistence & Immunogenicity of Hib-MenC VaccinePrevention
NCT00879827Immunogenicity and Reactogenicity of GSK Bio DTPa-HBV-IPV and Hib Vaccines When Coadministered to Healthy InfantsPrevention